Wockhardt (WOCKPHARMA)₹2,032+1.26%Pharmaceuticals
In the Jun 2026 quarter (consolidated), Wockhardt reported sales of ₹926 Cr, up 26.0% from Jun 2025, and net profit of ₹107 Cr. For the year to Mar 2026, sales were ₹3,364 Cr and net profit ₹199 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 750 | 699 | 697 | 737 | 806 | 718 | 741 | 735 | 780 | 885 | 962 | 926 |
| Expenses | 680 | 664 | 758 | 648 | 698 | 593 | 678 | 665 | 603 | 710 | 739 | 736 |
| Operating Profit | 72.24 | 37.11 | −59.16 | 91.28 | 110 | 128 | 64.16 | 72.16 | 178 | 177 | 226 | 193 |
| OPM % | 10.0% | 5.0% | −8.0% | 12.0% | 14.0% | 18.0% | 9.0% | 10.0% | 23.0% | 20.0% | 23.0% | 21.0% |
| Other Income | 23.95 | 7.98 | 9.98 | 29.98 | 8.99 | 7.99 | 14.98 | −76.91 | 20.98 | 14.99 | 66.87 | 30.95 |
| Interest | 76.23 | 77.18 | 73.20 | 73.27 | 73.20 | 60.19 | 48.14 | 48.14 | 55.12 | 60.16 | 50.17 | 52.13 |
| Depreciation | 55.03 | 55.03 | 57.99 | 54.01 | 55.04 | 55.03 | 53.03 | 55.98 | 53.04 | 65.04 | 52.98 | 54.99 |
| Profit before tax | −35.08 | −87.18 | −180 | −6.01 | −9.02 | 21.06 | −22.04 | −109 | 91.16 | 67.13 | 189 | 116 |
| Tax % | 109.0% | −1.0% | −2.0% | 167.0% | 78.0% | 5.0% | 105.0% | −1.0% | 10.1% | 9.0% | 13.0% | 8.0% |
| Exceptional items | 0.00 | 0.00 | −43.92 | 0.00 | 0.00 | 0.00 | 0.00 | −92.83 | 0.00 | −8.98 | 18.96 | 0.00 |
| Net Profit | −72.86 | −85.85 | −177 | −15.95 | −15.96 | 19.96 | −44.87 | −108 | 81.80 | 60.87 | 164 | 107 |
| EPS (Rs) | −5.32 | −5.74 | −10.98 | −0.90 | −1.42 | 0.85 | −1.53 | −5.52 | 4.78 | 3.62 | 10.18 | 6.50 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,440 | 3,999 | 3,927 | 3,553 | 2,834 | 2,698 | 3,218 | 2,642 | 2,787 | 3,004 | 3,364 | 3,553 |
| Expenses | 3,955 | 3,996 | 3,928 | 3,601 | 2,723 | 2,768 | 2,929 | 2,544 | 2,704 | 2,614 | 2,716 | 2,787 |
| Operating Profit | 496 | 13.04 | 2.01 | −38.10 | 119 | −63.13 | 299 | 102 | 91.25 | 394 | 654 | 774 |
| OPM % | 11.0% | 0.3% | 0.1% | −1.1% | 4.2% | −2.3% | 9.0% | 3.9% | 3.2% | 13.0% | 19.0% | 21.8% |
| Other Income | 65.90 | 114 | −238 | 116 | 133 | 974 | −163 | −173 | 16.97 | 61.90 | 25.95 | 134 |
| Interest | 129 | 226 | 256 | 266 | 277 | 250 | 300 | 303 | 306 | 255 | 214 | 218 |
| Depreciation | 142 | 149 | 150 | 164 | 224 | 246 | 247 | 251 | 223 | 217 | 227 | 226 |
| Profit before tax | 290 | −248 | −642 | −352 | −248 | 418 | −412 | −625 | −421 | −16.03 | 238 | 464 |
| Tax % | 13.1% | −9.0% | 4.0% | −38.0% | −82.0% | −65.0% | −32.0% | 0.0% | 12.0% | 256.0% | 16.0% | — |
| Exceptional items | 0.00 | 40.92 | −267 | 0.00 | 94.81 | −142 | −167 | −288 | −57.90 | 0.00 | −70.85 | 9.98 |
| Net Profit | 252 | −225 | −665 | −216 | −42.93 | 687 | −279 | −620 | −471 | −56.84 | 199 | 413 |
| EPS (Rs) | 17.38 | −13.57 | −42.18 | −13.47 | −4.80 | 47.46 | −16.87 | −38.66 | −30.08 | −2.88 | 13.06 | 25.08 |
| Dividend payout % | 0.0% | −56.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 54.86 | 54.85 | 54.79 | 54.79 | 54.77 | 54.78 | 54.82 | 71.78 | 71.78 | 76.72 | 80.67 | 80.78 |
| Reserves | 3,355 | 3,711 | 3,275 | 2,790 | 2,612 | 2,609 | 3,310 | 3,767 | 3,271 | 3,273 | 4,262 | 4,853 |
| Borrowings | 2,310 | 2,676 | 4,157 | 3,744 | 3,372 | 3,580 | 2,673 | 2,195 | 2,181 | 2,354 | 2,021 | 2,232 |
| Other Liabilities | 1,219 | 1,630 | 1,493 | 1,535 | 1,772 | 1,898 | 1,704 | 2,178 | 2,122 | 1,908 | 1,734 | 1,412 |
| Total Liabilities | 6,938 | 8,072 | 8,980 | 8,124 | 7,811 | 8,143 | 7,743 | 8,211 | 7,646 | 7,613 | 8,097 | 8,578 |
| Fixed Assets | 2,121 | 2,805 | 2,769 | 2,882 | 3,052 | 3,494 | 3,335 | 3,454 | 3,036 | 2,877 | 2,730 | 2,788 |
| CWIP | 1,009 | 1,038 | 1,247 | 1,437 | 1,450 | 1,588 | 1,382 | 1,346 | 1,543 | 1,727 | 2,038 | 2,385 |
| Investments | 341 | 0.00 | 563 | 214 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 422 | 412 |
| Other Assets | 3,467 | 4,228 | 4,401 | 3,590 | 3,309 | 3,060 | 3,025 | 3,411 | 3,067 | 3,009 | 2,908 | 2,993 |
| Inventories | 1,020 | 1,101 | 1,107 | 855 | 819 | 690 | 798 | 769 | 658 | 639 | 725 | 886 |
| Trade receivables | 740 | 1,109 | 1,033 | 961 | 1,273 | 1,240 | 916 | 917 | 796 | 617 | 660 | 587 |
| Cash & equivalents | 1,231 | 1,472 | 1,599 | 1,078 | 447 | 267 | 291 | 404 | 124 | 527 | 190 | 249 |
| Total Assets | 6,938 | 8,072 | 8,980 | 8,124 | 7,811 | 8,143 | 7,743 | 8,211 | 7,646 | 7,613 | 8,097 | 8,578 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 356 | −42.10 | −270 | 68.19 | 183 | 651 | −288 | 414 | 153 | 220 | −22.06 | 391 |
| Cash from investing activity | −223 | −105 | −686 | 636 | 93.09 | −147 | 1,473 | −204 | −118 | −138 | −781 | −231 |
| Cash from financing activity | −75.95 | 193 | 1,254 | −769 | −776 | −680 | −1,171 | −70.96 | −315 | 334 | 409 | −53.97 |
| Net cash flow | 56.88 | 45.86 | 300 | −65.86 | −499 | −177 | 12.96 | 138 | −279 | 414 | −392 | 105 |
| Capex | 441 | 63.04 | 412 | 307 | 275 | 172 | 166 | 212 | 209 | 216 | 365 | 364 |
| Free cash flow | −76.18 | −105 | −680 | −238 | 127 | 487 | −453 | 202 | 23.05 | 69.17 | −378 | 76.17 |
| CFO / OP % | 73.0% | −8.0% | −1,887.0% | 4,697.0% | −583.0% | 560.0% | 270.1% | 171.1% | 161.0% | 274.0% | −13.0% | 63.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 60 | 91 | 94 | 89 | 130 | 159 | 124 | 104 | 110 | 81 | 80 | 64 |
| Inventory days | 250 | 249 | 243 | 174 | 183 | 209 | 256 | 222 | 216 | 201 | 234 | 286 |
| Days payable | 137 | 145 | 118 | 123 | 188 | 273 | 224 | 266 | 286 | 241 | 192 | 183 |
| Cash conversion cycle | 176 | 197 | 221 | 142 | 127 | 98 | 158 | 61 | 42 | 42 | 124 | 169 |
| Working capital days | 14 | 52 | 36 | −56 | −51 | −171 | −133 | −116 | −186 | −163 | −23 | 35 |
| ROCE % | 10.0% | 7.0% | −1.0% | −1.0% | −1.0% | −1.0% | −3.0% | 1.0% | 0.0% | −1.0% | 4.0% | 8.0% |
For the Jun 2026 quarter, Wockhardt reported sales of ₹926 Cr, up 26.0% year on year and net profit of ₹107 Cr. The operating margin was 21.0%.
Wockhardt's sales for the year to Mar 2026 were ₹3,364 Cr; over the last twelve months they were ₹3,553 Cr.
Net profit for the year to Mar 2026 was ₹199 Cr, and ₹413 Cr over the last twelve months. Earnings per share over the same trailing period were ₹25.08.
Wockhardt reported borrowings of ₹2,232 Cr at Mar 2026, against cash and equivalents of ₹249 Cr.
Cash from operations was ₹391 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹76.17 Cr.